Pennsylvania 2025_0 Regular Session Status: In Committee 12 D cosponsors

HB 2181 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Last action — Referred to HEALTH, Jan. 30, 2026

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced January 30, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Prognosis

Stalled 26% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 12 sponsors

    1 primary, 11 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (12 D).

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Law Enforcement – Opioid Overdose Reversal Agents

Bill Text

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill amends the definition of 'opioid antagonist' in relation to drug overdose medication.

  • Section 13.8(h)

    As used in this section, the term "opioid antagonist" means a drug or device approved by the Federal Food, Drug, and Cosmetic Act (52 Stat. 1040, 21 U.S.C. § 301 et seq.) for emergency reversal of known or suspected opioid overdose, including naloxone hydrochloride, nalmefene hydrochloride or other similarly acting drugs approved by the United States Food and Drug Administration for the treatment of an opioid overdose.

    Defines 'opioid antagonist' to include specific drugs approved for opioid overdose reversal.

Action History

  1. Referred to HEALTH, Jan. 30, 2026

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 11 co-sponsors · 241 not signed on

Sponsors (1)

Co-sponsors (11)

Not signed on (241)

241 members have not signed on to this bill.

Show all 241 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2181 do?
Law Enforcement – Opioid Overdose Reversal Agents
Who sponsors HB 2181?
HB 2181 is sponsored by Brian Munroe (Democratic), Jennifer O'Mara (Democratic), G. Roni Green (Democratic), Chris Pielli (Democratic), Dan K. Williams (Democratic), Jeanne McNeill (Democratic), Carol Hill-Evans (Democratic), Benjamin V. Sanchez (Democratic), Liz Hanbidge (Democratic), Mary Jo Daley (Democratic), Johanny Cepeda-Freytiz (Democratic), and Lisa A. Borowski (Democratic).
What is the current status of HB 2181?
This bill is in committee in the House. Introduced January 30, 2026. It must pass committee before a floor vote.
Where can I track HB 2181?
Track HB 2181 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2181

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 2181

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →